Suboxone is a tightly-regulated, FDA-approved medicine designed and developed to
treat opioid use disorder (OUD). Like other advanced opioid addiction treatment options,
Suboxone is a key component of Medication-Assisted Treatment (MAT) programs.
Unlike other advanced medicinal options, Suboxone also prevents the opioid user from
experiencing the effects of opioids. This unique characteristic substantially helps
prevent opioid misuse and abuse.
Suboxone is a combination medicine containing buprenorphine and
naloxone. Buprenorphine is extensively used in MAT programs to help
people quit heroin and other opiates. Like Suboxone, buprenorphine is
tightly-regulated and approved by the FDA. And like Suboxone, it can only
be administered by certified and accredited Opioid Treatment Providers
Naloxone is an opioid agonist. It both competes with and blocks the effects
of other opioids, including buprenorphine. It also acts as an opioid
deterrent. Combining buprenorphine and naloxone therefore significantly
negates any opioid-related effects of the former, as well as any outside
opiates. The combination also significantly decreases the chances of opioid
relapse and/or overdose.